GPT and metabolic dysfunction-associated steatotic liver disease: When adjusting for various possible confounders (age, gender, levels of AFP, ALT, or GGT, diabetes, NAFLD, obesity, smoking status, essential hypertension, or history of ischemic cardiac disease), no significant changes in the AUROC values were achieved for the FIB-4 and APRI scores in predicting the risk of developing cirrhosis (Supplementary Figures S1 and S2, and Supplementary Table S3).